3D engineered tissue: Cellsion Tech’s bioprinted lifeline

ORGANIC GROWTH: Cellsion Applied sciences is an incubated enterprise
of the IISc Innovation Centre in Bengaluru

Contained in the 3D bioprinting lab at IISc-Bengaluru, engineers and biologists of Cellsion Applied sciences are immersed in an audacious enterprise: assembling liver tissue constructs (engineered 3D buildings) that recreate vascularisation, multicellularity and, in response to the corporate’s information, greater than 90 per cent of the organ’s practical enzymatic profile. Cellsion is constructing an extracorporeal liver help system (ECLD) — bioprinted tissue in disposable cassettes — that would maintain critically unwell sufferers within the ICU whereas they anticipate an organ transplant.

India performs 17,000-18,000 strong organ transplants annually, essentially the most after the US and China, however demand far outstrips provide, in response to the Nationwide Institute of Well being (NIH).

Whereas scientists worldwide discover organ regeneration, Bengaluru-based Cellsion’s bioprinted ECLD is being engineered to help sufferers within the ICU for prolonged durations, doubtlessly 2-3 months, till a donor is discovered, says Co-founder A Abdullah Chand.

The ink used for bioprinting liver tissue is created from human-grade extracellular matrix (ECM) supplies — the organic “cement” that helps cells adhere and performance in 3D.

Chand says the constructs replicate liver histology with vascular channels and multicell layers, and early information from lab testing present over 90 per cent correlation throughout enzymatic, genomic and proteomic markers versus native tissue.

The corporate has accomplished preclinical bench work, filed a provisional patent and is getting ready for research in giant, transplant-relevant animal fashions. The subsequent section includes constructing from prototypes to a clinical-grade system, which would require electronics, bioreactor methods and software program integration. Cellsion plans to hyperlink its platform to the Laboratory Info Administration System in order that clinicians can monitor cassette well being, metabolic efficiency and alerts in actual time.

Based in 2022 by Chand and N Nusrat Kalam, Cellsion Applied sciences is incubated on the IISc Innovation Centre and operates a satellite tv for pc lab off-campus. The beginning-up has acquired help from the Karnataka authorities’s IT/BT Ministry, aside from IISc grants, and is in talks for a follow-on funding spherical. Chand says Cellsion has additionally initiated a collaboration with US-based biotech inSphero, a recognised participant in industrial bioprinting.

Income stream

Whereas the 3D printing expertise will probably be restricted, the income will come from 3D bioprinted pores and skin fashions for sensitivity and hypersensitivity testing, Chand says. These are delivered as multi-well plates seeded with bioprinted cells that perform as mini-organs for drug discovery. Chand says the corporate at the moment caters to about 4 pharmaceutical analysis corporations.

The corporate additionally plans to develop kidney constructs — a logical extension, given the lengthy anticipate kidney transplants in India. Two lakh renal failure instances are registered annually as in opposition to 11,000 kidney transplants, in response to NIH.

Whereas full organ bioprinting stays a distant milestone, Cellsion’s bridge system guarantees a short lived reprieve for 1000’s of sufferers. “We’re not attempting to interchange transplantation,” Chand emphasises. “We’re shopping for sufferers essentially the most valuable useful resource — time.”

Extra Like This

Revealed on July 21, 2025